SODIUM CHLORIDE
Unresolved Excipient
Suggest One
No specific molecular structure known for this excipient.
- CAS
- 7647145
- UNII
- 451W47IQ8X
- SYNONYMS
-
- ZINC ID(s)
-
- Availability
- Present in 0 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).
(Browse) Purchasable Analogs in ZINC
Analogs cannot be located as there is no structure provided for this compound. Try a
search by name.
Regulatory Status of Sodium Chloride
| Gras - Generally recognized as safe. |
Dosages
| Route | Formulation | Per Unit Dose |
|---|---|---|
| Subcutaneous | Implant | 77MG |
| An,cnblk Intrathecal | Injection | 0.8% |
| An,sympathetic Nblk | Injection | 0.3% |
| Auricular (otic) | Solution | 9% |
| Auricular (otic) | Suspension | 0.86% |
| Auricular (otic) | Suspension, Liquid | 0.9% |
| Caudal Block | Injection | 0.9% |
| Dental | Injectable | 0.3% |
| Dental | Injection | 0.6% |
| Epidural | Injection | 0.86% |
| Epidural | Injection, Suspension, Liposomal | |
| Epidural | Solution, Injection | 0.9% |
| Extracorporeal | Injection | 0.9% |
| Extracorporeal | Solution | 0.8% |
| Im - Iv | Injectable | 0.9% |
| Im - Iv | Liquid, Water, Sterile, For Injection | 0.8% |
| Im - Iv | Powder, For Injection Solution | 9% |
| Im - Iv | Powder, For Injection Solution, Lyophilized | 18% |
| Im - Iv | Solution | 0.9% |
| Im - Iv | Solution, Injection | 0.49% |
| Im - Iv - Sc | Solution, Injection | |
| Im - Sc | Injection | 0.9% |
| Infiltration | Injection | 12% |
| Infiltration | Injection, Liposomal | 0.54% |
| Infiltration | Solution, Injection | 0.85% |
| Inhalation | Inhalant | |
| Inhalation | Suspension, For Inhalation | 0.85% |
| Intra-Arterial | Injectable | 0.49% |
| Intra-Arterial | Injection | 4.9% |
| Intra-Arterial | Powder, For Injection Solution | 0.14% |
| Intra-Arterial | Solution | 0.9% |
| Intra-Arterial | Solution, Injection | 0.49% |
| Intra-Articular | Injectable | 6.3% |
| Intra-Articular | Injection | 0.9% |
| Intra-Articular | Injection, Sustained Action | |
| Intra-Articular | Suspension | 0.48% |
| Intrabursal | Injection | 0.9% |
| Intracardiac | Injection | 0.7% |
| Intracardiac | Solution, Injection | |
| Intracaudal | Injection | 0.86% |
| Intracavitary | Injection | 0.82% |
| Intracavitary | Powder, For Injection Solution | |
| Intradermal | Injection | 0.7% |
| Intradermal | Injection, Sustained Action | |
| Intralesional | Injectable | 0.66% |
| Intralesional | Injection | 0.85% |
| Intralesional | Injection, Sustained Action | 0.9% |
| Intralesional | Suspension, Injection | 0.22% |
| Intramuscular | Injectable | 0.63%W/W |
| Intramuscular | Injection | 0.86% |
| Intramuscular | Injection | |
| Intramuscular | Injection, Sustained Action | 0.9% |
| Intramuscular | Liquid | 0.67% |
| Intramuscular | Powder, For Injection Solution | 22.6% |
| Intramuscular | Powder, For Injection Solution, Lyophilized, With Additives | 0.24% |
| Intramuscular | Solution, Injection | 0.9% |
| Intramuscular | Suspension | 0.9% |
| Intramuscular | Suspension, Injection | 0.87% |
| Intraocular | Solution | 0.7% |
| Intraperitoneal | Powder, For Injection Solution | 22.6% |
| Intraperitoneal | Solution | 0.54% |
| Intrapleural | Powder, For Injection Solution | 22.6% |
| Intrasynovial | Injection | 0.9% |
| Intrasynovial | Injection, Sustained Action | 0.9% |
| Intrasynovial | Suspension, Injection | 0.22% |
| Intrathecal | Injectable | 0.9% |
| Intrathecal | Injection | 4.9% |
| Intrathecal | Injection, Suspension, Liposomal | 9% |
| Intrathecal | Powder, For Injection Solution | 0.14% |
| Intrathecal | Solution, Injection | 0.49% |
| Intratracheal | Injection | 1.2% |
| Intratracheal | Powder, For Suspension | 4.68% |
| Intratracheal | Suspension | 0.76% |
| Intratracheal | Suspension, Injection | |
| Intratumor | Injectable | |
| Intratumor | Injection | 1.2% |
| Intratumor | Powder, For Injection Solution | |
| Intravascular | Injection | 0.19% |
| Intravascular | Solution | |
| Intravenous | Injectable | 0.9% |
| Intravenous | Injectable | 90% |
| Intravenous | Injection | 0.9% |
| Intravenous | Injection | |
| Intravenous | Liquid | 0.67% |
| Intravenous | Liquid, Water, Sterile, For Injection | 0.9% |
| Intravenous | Powder, For Injection Solution | 48.7% |
| Intravenous | Powder, For Injection Solution, Lyophilized | 45% |
| Intravenous | Powder, For Injection Solution, Lyophilized, With Additives | 3.15% |
| Intravenous | Solution | 0.9% |
| Intravenous | Solution, Injection | |
| Intravenous | Solution, Injection | 0.9%W/V |
| Intravenous | Solution, Injection | 0.9% |
| Intravenous Bolus | Injectable | 0.9% |
| Intravenous Bolus | Solution, Injection | 0.9% |
| Intravesical | Solution, Injection | 35.1% |
| Intravitreal | Injectable | 10% |
| Intravitreal | Injection | 0.77% |
| Intravitreal | Suspension, Injection | 0.55% |
| Iontophoresis | Drug Delivery System | 0.6MG |
| Iontophoresis | Patch, Controlled Release | 3.1MG |
| Iontophoresis | Solution | 0.6% |
| Iv - Sc | Injection | 9%W/V |
| Iv - Sc | Liquid | 0.7% |
| Iv - Sc | Powder, For Injection Solution | 0.68% |
| Iv - Sc | Solution, Injection | 0.9% |
| Iv(infusion) | Injectable | 0.85% |
| Iv(infusion) | Injection | 0.59% |
| Iv(infusion) | Injection | 45% |
| Iv(infusion) | Powder, For Injection Solution | 45% |
| Iv(infusion) | Powder, For Injection Solution, Lyophilized | |
| Iv(infusion) | Powder, For Injection Solution, Lyophilized, With Additives | 3.15% |
| Iv(infusion) | Solution, Injection | 0.9% |
| Iv(infusion) | Suspension, Injection | 0.9% |
| Nasal | Solution | 0.9% |
| Nasal | Solution, For Inhalation | 1.13% |
| Nasal | Spray | 0.7% |
| Nasal | Spray, Metered | 1.9% |
| Nerve Block | Solution, Injection | 0.9% |
| Ophthalmic | Drops | 0.65% |
| Ophthalmic | Gel | 0.9% |
| Ophthalmic | Powder, For Solution | 0.9% |
| Ophthalmic | Powder, For Suspension | |
| Ophthalmic | Solution | 0.81% |
| Ophthalmic | Solution | 0.4%W/W |
| Ophthalmic | Solution | 0.7% |
| Ophthalmic | Solution, Drops | 0.9% |
| Ophthalmic | Solution/drops | 0.41% |
| Ophthalmic | Suspension | 0.85% |
| Ophthalmic | Suspension, Drops | 0.68% |
| Oral | Capsule | 6MG |
| Oral | Capsule | |
| Oral | Capsule, Extended Release | 20.72MG |
| Oral | Drops | |
| Oral | Granule, For Suspension | 13.5MG |
| Oral | Powder, For Oral Solution | 33.69MG |
| Oral | Powder, For Oral Suspension | 0.1% |
| Oral | Powder, For Solution | |
| Oral | Powder, For Suspension | 0.25% |
| Oral | Solution | |
| Oral | Solution | 3% |
| Oral | Solution, Elixir | 0.04% |
| Oral | Solution, For Inhalation | 2.7% |
| Oral | Solution, Syrup | 0.04% |
| Oral | Suspension | 2% |
| Oral | Suspension, For Inhalation | 0.85% |
| Oral | Syrup | 0.3% |
| Oral | Tablet | 148MG |
| Oral | Tablet (immed./comp. Release), Uncoated, Chewable | 7.5MG |
| Oral | Tablet, Controlled Release | 25.5MG |
| Oral | Tablet, Controlled Release | 36MG |
| Oral | Tablet, Delayed Action | 24MG |
| Oral | Tablet, Extended Release | 335.1MG |
| Oral | Tablet, Orally Disintegrating | 2.5MG |
| Oral | Tablet, Orally Disintegrating | 10MG |
| Oral | Tablet, Sustained Action | 143.26MG |
| Oral | Tablet, Sustained Action, Coated | 46.8MG |
| Parenteral | Injection | 0.86% |
| Parenteral | Injection | 24% |
| Peridural | Injection | 0.81% |
| Perineural | Injection | 0.7% |
| Photopheresis | Solution | 0.8% |
| Rectal | Enema | 1.35GM |
| Rectal | Solution | |
| Rectal | Suppository | 52.5MG |
| Respiratory (inhalation) | Inhalant | 0.86% |
| Respiratory (inhalation) | Solution | 2.7% |
| Respiratory (inhalation) | Solution, Aerosol, For Inhalation | 0.23% |
| Respiratory (inhalation) | Solution, For Inhalation | 1.89% |
| Respiratory (inhalation) | Solution, For Inhalation | 2.7% |
| Retrobulbar | Injection | 0.86% |
| Route Not Given | Dosage Form Not Given | |
| See Dosage Form | Injection | 0.9% |
| Soft Tissue | Injectable | 0.66% |
| Soft Tissue | Injection | 0.85% |
| Soft Tissue | Injection, Sustained Action | 0.9% |
| Soft Tissue | Suspension, Injection | 0.22% |
| Subarachnoid | Solution, Injection | 0.9% |
| Subcutaneous | Injectable | 0.85% |
| Subcutaneous | Injection | 0.44% |
| Subcutaneous | Liquid | 0.15% |
| Subcutaneous | Solution | 0.7% |
| Subcutaneous | Solution, Injection | 2.25% |
| Subcutaneous | Suspension, Injection | 1.23% |
| Submucosal | Solution, Injection | 16% |
| Topical | Emulsion, Cream | |
| Topical | Gel | 0.18% |
| Topical | Jelly | |
| Topical | Lotion | 0.3% |
| Topical | Ointment | |
| Topical | Patch, Controlled Release | 3.1MG |
| Topical | Shampoo | 2.25% |
| Topical | Solution | 0.7%W/V |
| Topical | Solution | 0.9%W/V |
| Topical | Solution, Drops | 0.86%W/V |
| Topical | Suspension | 0.53% |
| Transdermal | Drug Delivery System | 0.6MG |